openPR Logo
Press release

Vaccines Market - Demand for Vaccines Is High In Countries Susceptible To Epidemic Diseases, Contributing To the Significant Market Growth

02-18-2019 10:55 AM CET | Health & Medicine

Press release from: Allied Market Research

Vaccines Market

Vaccines Market

The vaccine market is expected to grow at a CAGR of 10.9% from 2017 to 2023, reaching $ 6.514 billion by 2023. The combined vaccine sector accounted for more than one-third of the global market in 2016.

Vaccines use antigenic components to strengthen the immune system. This process helps develop adaptive immunity against pathogens and prevents morbidity from infection. Immunization plays an important role in anti-infectious strategies adopted in many countries. The high demand for vaccines in countries vulnerable to epidemics contributes to significant market growth.

The spread of vaccines and emerging vaccines for a variety of infectious diseases such as HIV, dengue and Zika virus infections is expected to accelerate the growth of the global vaccine market due to the high availability of the disease and the variety of techniques used to develop effective vaccines. future. In addition, government interest in vaccination programs can help raise awareness of the safety and availability of vaccines. However, it takes about 11-12 years to introduce a single vaccine into the commercial market. Prolonged development of these vaccines inhibits the development of new vaccines and hinders market growth. In addition, high monetary input in vaccine development will reduce adoption, further limiting growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/258

Key players operating in the vaccines market have adopted product launch as their key developmental strategy, and focus on launching innovative products to cater to the consumer requirements and strengthen their market share.
The major companies profiled in the report include
• Astellas Pharma Inc.
• Astrazeneca Plc. (Medimmune LLC.)
• CSL Limited
• Emergent Biosolutions Inc.
• Glaxosmithkline Plc.
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd

Due to the fact that Streptococcus pneumoniae (pathogenic bacteria) is the leading cause of infectious diseases worldwide, pneumococcal disease is expected to dominate over the forecast period and to achieve maximum market profit during the forecast period. In addition, the high prevalence of these diseases in the pediatric and elderly population and the increased demand for diverse serotype markings promote growth in this area. However, the human papillomavirus (HPV) sign increases from 2017 to 2023 with a high CAGR of 12.4%, the fourth most common type of sexually transmitted disease, especially among women with cervical cancer. Cancer prevalent in women.

The pediatric vaccine sector led the end-use market, which accounts for half of the total market share in 2016, due to the high immunization rate of infants and young people. Furthermore, active government involvement in revising vaccinations for all children has spurred market growth.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/258

Key Findings of the Vaccines Market:
• The recombinant vaccines segment is anticipated to grow at the highest growth rate during the forecast period.
• The human papilloma virus (HPV) vaccines segment is expected to grow at a rapid rate, registering a CAGR of 12.4% from 2017 to 2023.
• North America dominated the global vaccines market, accounting for maximum share of overall market in 2016.
• Asia-Pacific is exhibited to grow at a high growth rate of 12.0%, owing to the high demand for vaccination in densely populated area, such as India and China.
• The pediatric vaccines segment generated highest revenue in 2016, and is expected to continue its dominance in the future as well.
• The traveler vaccines segment is expected to exhibit high growth rate during forecast period, attributed by international travelers and mandated vaccination for immigrants before traveling.

Asia-Pacific has witnessed highest growth rate for vaccines, and is expected to continue this trend. This is attributed to increase in sizeable population, rise in incidence of HIV & cancer cases, healthcare infrastructural development, and huge market potential, owing to the new arrival of preventive, therapeutic, and adult vaccines by key players focusing on the emerging markets.

Access Full Summery @ https://www.alliedmarketresearch.com/vaccines-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccines Market - Demand for Vaccines Is High In Countries Susceptible To Epidemic Diseases, Contributing To the Significant Market Growth here

News-ID: 1595318 • Views: 215

More Releases from Allied Market Research

IV Quality Control Products Market is projected to reach $1,052 million by 2022, …
The global IVD quality control products market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% from 2016 to 2022. The quality controls products segment dominated the market with fourth-fifths share in 2015. Immunochemistry and clinical chemistry application segments together captured around half of the market share in 2015. Request a Sample Copy of the Research Report: @ https://www.alliedmarketresearch.com/request-sample/1792 "In
Electric Passenger Car Traction Motor Market Growth 2027 – Key drivers, Busine …
Traction motor produces resistance between two surfaces with or without using electricity. An electric passenger car traction motor is a vital component which is used for extracting electricity from the battery pack. Traction motor is installed in electric passenger vehicles to provide rotation torque for the movement of the car. Furthermore, stringent emission discharge norms and regulations drives the demand for electric passenger car. Moreover, quick expansion of EV charging
Electric Passenger Car Lithium-Ion Battery Management System Market Analysis of …
Electric passenger car has gained a considerable consumer popularity & acceptance in the past few years. Major improvements in the performance of an electric passenger car such as high acceleration rate and long driving range after a single charge have been boosting the demand for electric passenger vehicle. Further, a lithium-ion battery (LIB) is a type of rechargeable battery, which is popularly used in the field of electric passenger vehicles
Electric Bus Door System Market Trending Technologies, Developments, Key Players …
Buses have had a strong place in the transportation industry since the 1830s when the first steam bus was introduced in London. Since the year 1830, buses are considered as the most common mode of public transportation in almost every country across the world. Electric bus door system is an assembly of interconnected mechanisms which utilizes the power of electricity to automatically open the door. Furthermore, the electric bus

All 5 Releases


More Releases for Vaccines

Global Influenza Vaccines Market
Global Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027 Worldwide Influenza Vaccines Market size is expected to exceed USD 7.5 billion by 2027. The report contains a deep analysis of the worldwide influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the worldwide influenza vaccines market. The report also explores a detailed analysis
Designing multi-purpose vaccines
Scientists from the five year EU funded project MycoSynVac report their findings and successes at a final meeting in Brussels. The project drew on cutting edge biotechnology to explore three important GOALS: 1. TRANSFORM a living bacteria (Mycoplasma pneumoniae) into a vaccine chassis 2. APPLY this vaccine chassis against bacterial diseases in livestock animals, 3. CONTRIBUTE to the reduction of antibiotics administered to farm animals A well-rounded approach to science featuring
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA),